---
input_text: "Parental Attitudes Toward Deep Brain Stimulation in Adolescents with
  Treatment-Resistant Conditions. Objective: To examine parent's perceptions of deep
  brain stimulation (DBS) and whether DBS is perceived to be a viable and safe treatment
  for their adolescent child presenting with a severe, treatment-resistant neurological
  or psychiatric condition. Method: Two hundred and seventy-nine parents completed
  an online survey using Amazon Mechanical Turk (MTurk). Participants were presented
  with five vignette scenarios involving adolescents with severe, treatment-resistant
  neurological or psychiatric conditions: Rett syndrome, autism spectrum disorder,
  epilepsy, obsessive-compulsive disorder, and Tourette syndrome. Parents were then
  asked to evaluate each scenario and rate overall acceptability of using DBS to improve
  their child's core symptoms. Data were collected over a period of 2 weeks in the
  month of October 2018. Results: We found that parents reported favorable impressions
  of DBS regardless of the target condition, especially when greater improvement could
  be assured and when their child had the capacity to assist in the treatment decision-making.
  Parents indicated some reluctance to use DBS when possible safety concerns were
  present. Familiarity with DBS was directly associated with attitudes. Conclusions:
  The findings highlight an overall parental willingness to consider DBS as a treatment
  option for key symptoms of neurological and psychiatric conditions in adolescents."
raw_completion_output: |-
  primary_disease: <Rett syndrome; Autism spectrum disorder; Epilepsy; Obsessive-compulsive disorder; Tourette syndrome>

  medical_actions: <Deep brain stimulation>

  symptoms: <Core symptoms of Rett syndrome; Core symptoms of autism spectrum disorder; Core symptoms of epilepsy; Core symptoms of obsessive-compulsive disorder; Core symptoms of Tourette syndrome>

  chemicals: <>

  action_annotation_relationships: <Deep brain stimulation TREATS core symptoms IN Rett syndrome; Deep brain stimulation TREATS core symptoms IN Autism spectrum disorder; Deep brain stimulation TREATS core symptoms IN Epilepsy; Deep brain stimulation TREATS core symptoms IN Obsessive-compulsive disorder; Deep brain stimulation TREATS core symptoms IN Tourette syndrome>
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Deep brain stimulation TREATS core symptoms IN Tourette syndrome>

  ===

extracted_object:
  primary_disease: <Rett syndrome; Autism spectrum disorder; Epilepsy; Obsessive-compulsive
    disorder; Tourette syndrome>
  medical_actions:
    - <Deep brain stimulation>
  symptoms:
    - <Core symptoms of Rett syndrome
    - Core symptoms of autism spectrum disorder
    - Core symptoms of epilepsy
    - Core symptoms of obsessive-compulsive disorder
    - Core symptoms of Tourette syndrome>
  chemicals:
    - <>
  action_annotation_relationships:
    - subject: MAXO:0000943
      predicate: TREATS
      object: core symptoms
      qualifier: MONDO:0010726
    - subject: MAXO:0000943
      predicate: TREATS
      object: core symptoms
      qualifier: MONDO:0005258
    - subject: MAXO:0000943
      predicate: TREATS
      object: core symptoms
      qualifier: MONDO:0005027
    - subject: MAXO:0000943
      predicate: TREATS
      object: core symptoms
      qualifier: MONDO:0008114
    - subject: MAXO:0000943
      predicate: TREATS
      object: core symptoms
      qualifier: MONDO:0007661
named_entities:
  - id: MONDO:0005647
    label: Genital warts
  - id: MONDO:0002602
    label: Central nervous system diseases
  - id: HP:0002011
    label: central nervous system diseases
  - id: MONDO:0010726
    label: Rett syndrome
  - id: MONDO:0005027
    label: epilepsy
  - id: HP:0001250
    label: seizures
  - id: MAXO:0001298
    label: therapy
  - id: HP:0002186
    label: apraxia
  - id: HP:0002333
    label: motor deterioration
  - id: CHEBI:229599
    label: Trofinetide
  - id: HP:0012444
    label: Brain atrophy
  - id: CHEBI:182159
    label: Cannabidivarin (CBDV)
  - id: HP:0012531
    label: Pain
  - id: MAXO:0001001
    label: Gene therapy
  - id: HP:0002540
    label: inability to walk
  - id: HP:0002300
    label: inability to speak
  - id: HP:0000787
    label: Nephrolithiasis
  - id: HP:0000016
    label: Urinary retention
  - id: MAXO:0000759
    label: HPV vaccination
  - id: MAXO:0000790
    label: Breast examinations
  - id: MAXO:0000793
    label: Pelvic examinations
  - id: HP:0100543
    label: Cognitive dysfunction
  - id: MONDO:0100039
    label: CDKL5 disorder
  - id: MAXO:0009101
    label: Early intervention
  - id: CHEBI:176843
    label: Vitamin B12
  - id: CHEBI:16347
    label: Levocarnitine
  - id: CHEBI:26708
    label: NA
  - id: CHEBI:7421
    label: N-acetyl cysteine (NAC)
  - id: CHEBI:46895
    label: LPS
  - id: CHEBI:17561
    label: L-cysteine
  - id: HP:0002360
    label: Sleep disturbances
  - id: MAXO:0000458
    label: Hydrotherapy
  - id: MAXO:0000011
    label: Physical therapy
  - id: HP:0001251
    label: Ataxia
  - id: CHEBI:75883
    label: Magnetic Nanoparticle-Assisted Genome Editing (MAGE)
  - id: MONDO:0005560
    label: Brain Disorders
  - id: HP:0001298
    label: Brain Disorders
  - id: HP:0002376
    label: developmental regression
  - id: HP:0000708
    label: Behavioural problems
  - id: HP:0002607
    label: Bowel incontinence
  - id: HP:0002094
    label: Breathing difficulties
  - id: HP:0002019
    label: Constipation
  - id: HP:0011968
    label: Feeding difficulties
  - id: HP:0000020
    label: Urinary incontinence
  - id: MONDO:0001071
    label: Intellectual disability
  - id: CHEBI:3638
    label: Chloroquine
  - id: MAXO:0000943
    label: Forniceal deep brain stimulation (DBS)
  - id: HP:0002354
    label: Memory impairment
  - id: CHEBI:191875
    label: denoising source separation (DSS) algorithm
  - id: CHEBI:4806
    label: Epigallocatechin gallate (EGCG)
  - id: CHEBI:27881
    label: Resveratrol
  - id: CHEBI:46245
    label: Coenzyme Q10 (CoQ10)
  - id: CHEBI:176783
    label: Vitamin C
  - id: CHEBI:33234
    label: Vitamin E
  - id: CHEBI:15422
    label: ATP
  - id: CHEBI:13389
    label: NAD
  - id: CHEBI:15996
    label: GTP
  - id: CHEBI:16856
    label: GSH
  - id: CHEBI:17858
    label: GSSG
  - id: CHEBI:566274
    label: Malondialdehyde (MDA)
  - id: MAXO:0001394
    label: Oral administration
  - id: HP:0025464
    label: Oxidative stress
  - id: MONDO:0700092
    label: Neurodevelopmental disorders (NDDs)
  - id: MONDO:0006664
    label: Autism Spectrum Disorder (ASD) and related neurogenetic syndromes
  - id: MAXO:0000506
    label: Noninvasive ventilation
  - id: MAXO:0000617
    label: Pulse oximetry
  - id: HP:0002791
    label: Hypoventilation
  - id: HP:0001249
    label: intellectual disability
  - id: HP:0000729
    label: Autistic behaviors
  - id: MONDO:0012589
    label: Pitt Hopkins syndrome (PTHS)
  - id: HP:0001257
    label: spasticity
  - id: MONDO:0000396
    label: Spastic Cerebral Palsy
  - id: HP:0002783
    label: Lower respiratory tract infection (LRTI)
  - id: MAXO:0000127
    label: Genetic testing
  - id: HP:0012757
    label: Abnormal neuronal morphology
  - id: CHEBI:31236
    label: Aripiprazole
  - id: CHEBI:8871
    label: Risperidone
  - id: CHEBI:70735
    label: Lurasidone
  - id: CHEBI:33349
    label: <forniceal deep brain stimulation (DBS)>
  - id: MONDO:0004975
    label: Alzheimer's disease
  - id: MAXO:0000942
    label: Vagus nerve stimulation (VNS)
  - id: HP:0002133
    label: Status epilepticus
  - id: MAXO:0001610
    label: paired-pulse transcranial magnetic stimulation (TMS) protocols
  - id: HP:0002104
    label: apneas
  - id: MONDO:0021200
    label: Rare diseases
  - id: HP:0000739
    label: Anxiety
  - id: MONDO:0005559
    label: Neurodegeneration
  - id: CHEBI:50131
    label: 5-aza-2'-deoxycytidine (Aza)
  - id: CHEBI:230514
    label: M4
  - id: HP:0002871
    label: Central apneas
  - id: HP:0001376
    label: Decreased joint mobility
  - id: CHEBI:16865
    label: gamma-aminobutyric acid (GABA)
  - id: MONDO:0005258
    label: Autism spectrum disorder
  - id: MONDO:0008114
    label: Obsessive-compulsive disorder
  - id: MONDO:0007661
    label: Tourette syndrome
